Breastfeeding in survivors of Hodgkin lymphoma treated with chest radiotherapy

Cancer
Laura McCulloughLisa Diller

Abstract

Female survivors of therapeutic chest radiation often question whether they will have difficulty with breast feeding, given their prior exposure to breast radiation. In the current study, the rates of successful breastfeeding in long-term survivors who received chest radiotherapy (CXRT) as a treatment for Hodgkin lymphoma (HL) were examined. A survey study of survivors of HL who were treated at the Joint Center for Radiation Therapy in Boston from 1969 through 1996 was performed. Patients were queried about childbearing and breastfeeding. The authors analyzed self-reported breastfeeding success in women who reported live births after CXRT and compared them with a sibling control group. Overall, 83 female survivors of HL who were treated with CXRT reported at least 1 birth after treatment. There were a total of 141 post-HL pregnancies resulting in births. In these women, the median age at the time of the HL diagnosis was 23 years (range, 14-40 years) and the median radiation dose was 41 grays (Gy) (range, 27-46 Gy). For survivors, 57 of the 94 (61%) breastfeeding attempts were successful, whereas within the control group, 74 of the 94 (79%) attempts were successful (P = .044). Accounting for maternal age at first birth and birth...Continue Reading

References

Aug 1, 1992·Cancer·A J JanovR B Weiss
Feb 1, 1991·Journal of Surgical Oncology·G Varsos, J Yahalom
Jul 1, 1989·International Journal of Radiation Oncology, Biology, Physics·J P Green
Jul 1, 1989·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·A RodgerU Chetty
Jul 1, 1985·International Journal of Radiation Oncology, Biology, Physics·F C David
Aug 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R DoriaD L Cooper
Feb 1, 1995·American Journal of Clinical Oncology·A H Tralins
Mar 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·O BeatyC B Pratt
Feb 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F E van LeeuwenR Somers
Jan 1, 1994·Medical and Pediatric Oncology·D M GreenE A Stephens
Jan 13, 1994·The New England Journal of Medicine·P A NewcombB MacMahon
Oct 27, 1993·JAMA : the Journal of the American Medical Association·S L HancockR T Hoppe
Feb 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J F AbrahamsenH Høst
Mar 15, 1996·American Journal of Epidemiology·I RomieuR Romero-Jaime
Mar 1, 1996·British Journal of Cancer·K KatsouyanniD Trichopoulos
Dec 7, 1996·Lancet·K B MichelsW C Willett
Feb 8, 2000·International Journal of Radiation Oncology, Biology, Physics·B GuixA Martínez
Feb 17, 2000·Journal of the National Cancer Institute·L LipworthD Trichopoulos
Aug 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Graça M DoresLois B Travis
Oct 22, 2002·American Journal of Obstetrics and Gynecology·Daniel M GreenLeslie L Robison
Nov 7, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A Foss AbrahamsenS Kvaløy
Nov 29, 2002·Pediatrics·Alan S RyanAndrew Acosta
Apr 22, 2003·International Journal of Cancer. Journal International Du Cancer·Soon Young LeeSoo Jin Yoon
Jul 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M Jacob AdamsSteven E Lipshultz
Mar 24, 2005·Journal of the National Cancer Institute. Monographs·Rajaram Nagarajan, Leslie L Robison
Apr 2, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P DasP M Mauch
Oct 18, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A K NgL Diller
Nov 2, 2005·The Cancer Journal·Meena S MoranSusan A Higgins
Mar 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David C HodgsonLois B Travis
Sep 4, 2007·Evidence Report/technology Assessment·Stanley IpJoseph Lau
Feb 1, 2008·International Journal of Radiation Oncology, Biology, Physics·Andrea K NgPeter M Mauch

❮ Previous
Next ❯

Citations

Jun 24, 2011·Breast Cancer Research and Treatment·Olivia PaganiUNKNOWN North American Breast Cancer Group Endocrine Working Group
Jan 22, 2011·Journal of Cancer Survivorship : Research and Practice·Susan W OggJames L Klosky
Feb 15, 2013·Expert Review of Anticancer Therapy·Sarah Campos LealHeloisa de Andrade Carvalho
Feb 25, 2017·The Oncologist·Shlomit Strulov ShacharCarey K Anders
Apr 16, 2020·Journal of Cancer Survivorship : Research and Practice·Susan OggMelissa M Hudson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
A RodgerU Chetty
International Journal of Radiation Oncology, Biology, Physics
H U Ulmer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Christine Mauz-KörholzDieter Körholz
© 2021 Meta ULC. All rights reserved